Persisting aluminium-related bone disease after cadaveric renal transplantation.
Nicholas
J C
JC
North Staffordshire Royal Infirmary, Stoke on Trent, UK.
Dawes
P T
PT
Davies
S J
SJ
Freemont
A J
AJ
D000536:Aluminum Hydroxide / Q000009:adverse effects*; D001706:Biopsy; D001847:Bone Diseases / Q000139:chemically induced* / Q000188:drug therapy; D001842:Bone and Bones / Q000473:pathology; D002102:Cadaver; D002614:Chelating Agents / Q000627:therapeutic use*; D003676:Deferoxamine / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation; D011183:Postoperative Complications; D006435:Renal Dialysis / Q000009:adverse effects*
D002614:Chelating Agents; D000536:Aluminum Hydroxide; D003676:Deferoxamine